SENSIA, S.L.

* Nanobiotechnology
* Biosensors
* Nanomedicine
* Biofuncionalization

*   O.Zagorodko, J. Spadavecchia, A. Yanguas Serrano, I. Larroulet, A. Pesquera, A.Zurutuza, R. Boukherroub, and Sabine Szunerits - Rabah Boukherroub and Sabine Szunerits : Anal. Chem., 2014, 86, 11211-11216. PDF

*   K. Turcheniuk, C-H. Hage, J. Spadavecchia, A. Yanguas Serrano, I. Larroulet, A. Pesquera, A. Zurutuza, M. Gonzales Pisfil, L. Heliot, J. Bouckaert, - Rabah Boukherroub , and Sabine Szunerits: J. Mater. Chem. B, 2015, 3, 375

*   O.Zagorodko , J. Bouckaert , T. Dumych , R. Bilyy , I. Larroulet , A. Yanguas Serrano , D. Alvarez Dorta , S. G. Gouin , Stefan-Ovidiu Dima , - Florin Oancea , Rabah Boukherroub , and Sabine Szunerits : Biosensors 2015, 5(2), 276-287

Useful web links or contacts for NANOSPAIN Network

www.sensia.es, www.nanobasque.eu, www.mondragoncorporation.com

Other relevant information

SENSIA is a technological leader company in the field of analytical instrumentation based on SPR (Surface Plasmon Resonance), for life sciences laboratories and environmental measurements. Sensia has developed in 2014 an innovative SPR (Surface Plasmon Resonance) solution, using graphene biosensing and introducing into the market the first available commercial graphene biosensors, in a device whose microfluidics have been conceived to withstand the use of bacteria and/or of nanoparticles. The conception of the optical system enables extreme versatility, allowing the indifferent use of gold biosensors, of graphene coated biosensors, and of silica coated biosensors, with no required change of geometry of the optical platform, although the refractive indexes change. Several strategies of immobilization can be therefore used with this SPR solution. The combination of graphene biosensors and of nanoparticles lead to new unattained limits of detection, into the attomolar range. SENSIA is a company of the Mondragón Group.